SHIOKAWA et al. V. MAIENFISCH et al. - Page 53




                                The depicted formula and caption do not demonstrate a concession by Dr. Maienfisch that the                                                            

                     ‘146 patent describes O and S in the middle position of the Z-chain.  At best, the formula and                                                                    

                     corresponding caption show that sometime after 1989, i.e., >1989, Novartis and others were aware of                                                               

                     the depicted compound.  It is not clear that the reference to “others” in the caption is a reference to the                                                       

                     inventors of the ‘146 patent.  Further, it is not clear that the reference to >1989                                                                               

                     refers to the publication of Shiokawa JP ‘943 as opposed to the filing of Maienfisch’s EP 483,055                                                                 

                     Swiss priority document and/or the later filed Maienfisch ‘664 disclosure.  The depicted formula and                                                              

                     caption do not demonstrate that the ‘146 patent directed one skilled in the art to the claimed 1,3,5-                                                             

                     oxadiazines.                                                                                                                                                      



                                D.         Shiokawa Preliminary Motion 4 that Maienfisch’s Claims are Unpatentable over Prior                                                          
                                           Art                                                                                                                                         

                                Shiokawa’s Japanese patent application JP 1-54943 (“JP ‘943") was published on September                                                               

                     18, 1990 and is available as prior art under 35 U.S.C. 102(b) as to Maienfisch’s U.S. 09/136,664                                                                  
                     application.   JP ‘943 describes heterocyclic compounds and insecticidal compositions and methods19                                                                                                                                               

                     employing the heterocyclic compounds as the active component.  (Certified Translation of JP ‘493, SX                                                              

                     2023, pages 1-3).  Maienfisch’s claimed compounds, with the exception of the tautomers, fall within the                                                           

                     literal scope of the heterocyclic compounds described by JP ‘943 and a majority of Maienfisch’s                                                                   


                                19Shiokawa also contends that Maienfisch ‘664 is unpatentable over Shiokawa U.S. Patent No.                                                            
                     5,032,589.  (Shiokawa Preliminary Motion 4, Paper No. 37, p. 1).  Shiokawa’s U.S. Patent and laid                                                                 
                     open JP publication are “substantively identical.”  (Shiokawa Preliminary Motion 4, p. 2).  As the                                                                
                     disclosures of the two documents are substantively identical we discuss the patentability of Maienfisch                                                           
                     ‘664 with respect to Shiokawa’s laid open JP publication with the understanding that the analysis would                                                           
                     be the same as that for Shiokawa’s 5,032,589 patent.                                                                                                              
                                                                                         51                                                                                            





Page:  Previous  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  Next 

Last modified: November 3, 2007